NMN Nicotinamide Mononucleotide
Nicotinamide mononucleotide (“NMN”, “NAMN”, and “β-NMN”) is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
Nicotinamide mononucleotide(NMN) in human cells play an important role in energy generation, it involved in intracellular NAD (nicotinamide adenine dinucleotide, cell energy conversion important coenzyme) synthesis, used in anti-aging, fall blood sugar and other health care products.
1. Cosmetic raw material:
NMN itself is a substance in the body of cells, and its safety as a drug or health care product is high, and NMN is a monomer molecule,it’s anti-aging effect is obvious, so it can be used in cosmetic raw materials.
2.Health care products:
Niacinamide mononucleotide (NMN) can be prepared by yeast fermentation, chemical synthesis or in vitro enzymatic catalysis. It widely used in the health care industry.
Specification of Beta-Nicotinamide Mononucleotide (NMN)
|Product name||Beta-Nicotinamide Mononucleotide||Other name||NMN/Nicotinamide nucleotide|
|Appearance||White to off-white powder||PubChem CID||16219737|
Certificate Of Analysis
|Product Name:||β-nicotinamide mononucleotide||CAS No.:||1094-61-7|
|Representative QTY:||100 Kg||Produce Date:||Mar 10, 2020|
|Analysis Date:||Jan 11, 2021||Expiration Date:||Jan,9, 2023|
Appearance of solution
Loss and drying
Aerobic bacterial count
Molds and yeasts
Total microbial count(GB 4789.2)
|White to off-white Powder
Clear and colorless
Maximum 3*104 CFU/g
Maximum 0.92 MPN/g
Maximum 50 CFU/g
Maximum 0/25 g
98.0% to 101.0%